You searched for "pregnancy"
The choroid in pregnancy
1 October 2014
| Khadijah Basheer
|
Retina / Uvea / Vitreous
During pregnancy there can be different types of ocular changes including a decrease in corneal sensitivity, increase in central corneal thickness and curvature, decrease in intraocular pressure, central serous chorioretinopathy and ocular blood flow. Advances in ophthalmic imaging devices has...
Effect of pregnancy on myopia
1 December 2017
| Sofia Rokerya
|
Retina / Uvea / Vitreous
The authors present a longitudinal study with a large sample size assessing the association between pregnancy and the onset or progression of myopia. The study participants included the SUN cohort which comprised of young adult female university graduates in Spain....
Ranibizumab safety in pregnancy
1 December 2018
| Sofia Rokerya
|
Retina / Uvea / Vitreous
Vascular endothelial growth factor (VEGF) plays a pivotal role during pregnancy, and systemic anti-VEGF administration during this period should thus be avoided. VEGF is expressed in multiple embryonic and foetal tissues during development, with the highest levels found in the...
Diabetes macular oedema in pregnancy self-resolving postpartum
1 October 2021
| Rajesh Deshmukh, Antony Raharja, Li Teng Kok
|
Ophthalmology, Retina / Uvea / Vitreous, Imaging
*Equally contributing co-first authors. Diabetic macular oedema (DMO) is a common clinical presentation to ophthalmology clinics. Ample evidence exists for management of DMO in non-pregnant patients. However, there is a paucity of evidence on the optimal management of DMO in...
Does pregnancy cause progression of keratoconus in previously cross-linked corneas?
3 October 2022
| Mahmoud Ahmed
|
Cornea / External Eye Disease
This is a prospective study involving 24 eyes of 19 patients with stabilised or regressed keratoconus after a successful accelerated cross linking (A-CXL) treatment. Patients were recruited at a routine follow-up visit in the first month of their pregnancy. The...
Moorfields: Pregnancy considerations in women with eye disease- a day of ophthalmology for obstetricians
16 May 2025
Ophthalmic conditions are common in women of childbearing age, and treatments for these are evolving at a fast pace. When these women become pregnant, the obstetrician may be unfamiliar with the effect of pregnancy on their eye condition, the medications...
Moorfields pregnancy considerations in women with eye disease: a day of ophthalmology for obstetricians
16 May 2025
Ophthalmic conditions are common in women of childbearing age, and treatments for these are evolving at a fast pace. When these women become pregnant, the obstetrician may be unfamiliar with the effect of pregnancy on their eye condition, the medications...
Moorfields: Pregnancy considerations in women with eye disease: a day of obstetrics for ophthalmologists
10 March 2025
Ophthalmic conditions are common in women of childbearing age, and treatments for these are evolving at a fast pace. When these women become pregnant, a common source of anxiety is both the potential continuation of these medications, as well as...
Moorfields pregnancy considerations in women with eye disease: a day of obstetrics for ophthalmologists
10 March 2025
Ophthalmic conditions are common in women of childbearing age, and treatments for these are evolving at a fast pace. When these women become pregnant, a common source of anxiety is both the potential continuation of these medications, as well as...
Eye disorders occurring in congenital CMV
11 January 2024
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
The aim of this study was to examine the relationship between congenital cytomegalovirus (CMV) infection and ophthalmological disorders that occur in children and record the frequency and type of eye disorders that occur from the infection. Of 449 potential studies,...
2018 update on intravitreal injections
1 December 2018
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Intravitreal injections, Treatment of retinal diseases, Vitreoretinal diseases
In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...
Addressing medical risk factors for diabetes and understanding the new systemic treatments
1 February 2014
| Samantha S Mann
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...